2017-2022 Global Top Countries Biologics and Biosimilars Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
This report studies Biologics and Biosimilars in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering
This report studies Biologics and Biosimilars in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
- 1 United States
- 2 Canada
- 3 Mexico
- 4 Germany
- 5 France
- 6 UK
- 7 Italy
- 8 Russia
- 9 China
- 10 Japan
- 11 India
- 12 Korea
- 13 Southeast Asia
- 14 Australia
- 15 Brazil
- 16 Middle East
- 17 Africa
- Antibody
- Hormone
- Growth Factors
- Other
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
2017-2022 GLOBAL TOP COUNTRIES BIOLOGICS AND BIOSIMILARS MARKET REPORT
1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Types
1.2.1 Global Sales Market Share of Biologics and Biosimilars by Types in 2015
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Biologics and Biosimilars Segment by Applications
1.3.1 Biologics and Biosimilars Consumption Market Share by Applications in 2015
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Biologics and Biosimilars Market by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Canada Status and Prospect (2012-2022)
1.4.3 Germany Status and Prospect (2012-2022)
1.4.4 France Status and Prospect (2012-2022)
1.4.5 UK Status and Prospect (2012-2022)
1.4.6 Italy Status and Prospect (2012-2022)
1.4.7 Russia Status and Prospect (2012-2022)
1.4.8 China Status and Prospect (2012-2022)
1.4.9 Japan Status and Prospect (2012-2022)
1.4.10 India Status and Prospect (2012-2022)
1.4.11 Korea Status and Prospect (2012-2022)
1.4.12 Southeast Asia Status and Prospect (2012-2022)
1.4.13 Australia Status and Prospect (2012-2022)
1.4.14 Brazil Status and Prospect (2012-2022)
1.4.15 Mexico Status and Prospect (2012-2022)
1.4.16 Middle East Status and Prospect (2012-2022)
1.4.17 Africa Status and Prospect (2012-2022)
1.5 Global Biologics and Biosimilars Overview and Market Size (Value) (2012-2022)
1.5.1 Global Market Biologics and Biosimilars Overview
1.5.2 Global Market Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
2 GLOBAL BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) AND MARKET SHARE BY MANUFACTURERS
2.1 Global Biologics and Biosimilars Sales and Market Share in 2015 and 2016 by Manufacturers
2.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturers in 2015 and 2016
2.3 Global Biologics and Biosimilars Average Price by Manufacturers in 2015 and 2016
2.4 Global Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
2.5 Biologics and Biosimilars Market Competitive Situation and Trends
2.5.1 Biologics and Biosimilars Market Concentration Rate
2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 GLOBAL BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
3.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
3.1.1 Global Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
3.1.3 Global Biologics and Biosimilars Price by Countries (2012-2017)
3.2 Global Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
3.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
3.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
3.2.3 Global Biologics and Biosimilars Price by Type (2012-2017)
3.3 Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
3.4 Global Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4 GLOBAL BIOLOGICS AND BIOSIMILARS MANUFACTURERS PROFILES/ANALYSIS
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Biologics and Biosimilars Product Types, Application and Specification
4.1.2.1 Type
4.1.2.2 Type
4.1.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.2 Amgen
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Biologics and Biosimilars Product Types, Application and Specification
4.2.2.1 Type
4.2.2.2 Type
4.2.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.3 AbbVie
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Biologics and Biosimilars Product Types, Application and Specification
4.3.2.1 Type
4.3.2.2 Type
4.3.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.4 Sanofi-Aventis
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Biologics and Biosimilars Product Types, Application and Specification
4.4.2.1 Type
4.4.2.2 Type
4.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.5 Johnson & Johnson
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Biologics and Biosimilars Product Types, Application and Specification
4.5.2.1 Type
4.5.2.2 Type
4.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.6 Pfizer
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Biologics and Biosimilars Product Types, Application and Specification
4.6.2.1 Type
4.6.2.2 Type
4.6.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.7 Novo Nordisk
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Biologics and Biosimilars Product Types, Application and Specification
4.7.2.1 Type
4.7.2.2 Type
4.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.8 Eli Lilly
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Biologics and Biosimilars Product Types, Application and Specification
4.8.2.1 Type
4.8.2.2 Type
4.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.9 Novartis
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Biologics and Biosimilars Product Types, Application and Specification
4.9.2.1 Type
4.9.2.2 Type
4.9.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.9.4 Main Business/Business Overview
4.10 Merck
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Biologics and Biosimilars Product Types, Application and Specification
4.10.2.1 Type
4.10.2.2 Type
4.10.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.10.4 Main Business/Business Overview
4.11 3sbio
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Biologics and Biosimilars Product Types, Application and Specification
4.11.2.1 Type
4.11.2.2 Type
4.11.3 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.11.4 Main Business/Business Overview
4.12 Changchun High Tech
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Biologics and Biosimilars Product Types, Application and Specification
4.12.2.1 Type
4.12.2.2 Type
4.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.12.4 Main Business/Business Overview
4.13 CP Guojian
4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.13.2 Biologics and Biosimilars Product Types, Application and Specification
4.13.2.1 Type
4.13.2.2 Type
4.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.13.4 Main Business/Business Overview
4.14 Biotech
4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.14.2 Biologics and Biosimilars Product Types, Application and Specification
4.14.2.1 Type
4.14.2.2 Type
4.14.3 Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.14.4 Main Business/Business Overview
4.15 Gelgen
4.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.15.2 Biologics and Biosimilars Product Types, Application and Specification
4.15.2.1 Type
4.15.2.2 Type
4.15.3 Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.15.4 Main Business/Business Overview
4.16 Innovent
4.16.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.16.2 Biologics and Biosimilars Product Types, Application and Specification
4.16.2.1 Type
4.16.2.2 Type
4.16.3 Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.16.4 Main Business/Business Overview
4.17 Dong Bao
4.17.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.17.2 Biologics and Biosimilars Product Types, Application and Specification
4.17.2.1 Type
4.17.2.2 Type
4.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.17.4 Main Business/Business Overview
4.18 Ganlee
4.18.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.18.2 Biologics and Biosimilars Product Types, Application and Specification
4.18.2.1 Type
4.18.2.2 Type
4.18.3 Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.18.4 Main Business/Business Overview
4.19 United Laboratories
4.19.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.19.2 Biologics and Biosimilars Product Types, Application and Specification
4.19.2.1 Type
4.19.2.2 Type
4.19.3 United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.19.4 Main Business/Business Overview
5 NORTH AMERICA BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
5.1.3 North America Biologics and Biosimilars Price by Countries (2012-2017)
5.1.4 North America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
5.1.5 North America Biologics and Biosimilars Import & Export (2012-2017)
5.2 United States Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
5.2.1 United States Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
5.2.2 United States Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
5.2.3 United States Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.2.4 United States Biologics and Biosimilars Price by Type (2012-2017)
5.2.5 United States Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
5.3 Canada Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
5.3.1 Canada Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
5.3.2 Canada Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
5.3.3 Canada Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.3.4 Canada Biologics and Biosimilars Price by Type (2012-2017)
5.3.5 Canada Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
6 LATIN AMERICA BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
6.1 Latin America Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
6.1.1 Latin America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
6.1.2 Latin America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
6.1.3 Latin America Biologics and Biosimilars Price by Countries (2012-2017)
6.1.4 Latin America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.5 Latin America Biologics and Biosimilars Import & Export (2012-2017)
6.2 Mexico Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
6.2.1 Mexico Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
6.2.2 Mexico Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
6.2.3 Mexico Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
6.2.4 Mexico Biologics and Biosimilars Price by Type (2012-2017)
6.2.5 Mexico Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
6.3 Brazil Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
6.3.1 Brazil Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
6.3.2 Brazil Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
6.3.3 Brazil Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
6.3.4 Brazil Biologics and Biosimilars Price by Type (2012-2017)
6.3.5 Brazil Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7 EUROPE BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
7.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
7.1.1 Europe Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
7.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
7.1.3 Europe Biologics and Biosimilars Price by Countries (2012-2017)
7.1.4 Europe Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
7.1.5 Europe Biologics and Biosimilars Import & Export (2012-2017)
7.2 Germany Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.2.1 Germany Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.2.2 Germany Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.2.3 Germany Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.2.4 Germany Biologics and Biosimilars Price by Type (2012-2017)
7.2.5 Germany Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.3 France Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.3.1 France Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.3.2 France Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.3.3 France Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.3.4 France Biologics and Biosimilars Price by Type (2012-2017)
7.3.5 France Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.4 UK Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.4.1 UK Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.4.2 UK Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.4.3 UK Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.4.4 UK Biologics and Biosimilars Price by Type (2012-2017)
7.4.5 UK Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.5 Italy Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.5.1 Italy Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.5.2 Italy Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.5.3 Italy Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.5.4 Italy Biologics and Biosimilars Price by Type (2012-2017)
7.5.5 Italy Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.6 Russia Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.6.1 Russia Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.6.2 Russia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.6.3 Russia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.6.4 Russia Biologics and Biosimilars Price by Type (2012-2017)
7.6.5 Russia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
8.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
8.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
8.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
8.1.3 Asia-Pacific Biologics and Biosimilars Price by Countries (2012-2017)
8.1.4 Asia-Pacific Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
8.1.5 Asia-Pacific Biologics and Biosimilars Import & Export (2012-2017)
8.2 China Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.2.1 China Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.2.2 China Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.2.3 China Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.2.4 China Biologics and Biosimilars Price by Type (2012-2017)
8.2.5 China Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.3 Japan Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.3.1 Japan Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.3.2 Japan Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.3.3 Japan Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.3.4 Japan Biologics and Biosimilars Price by Type (2012-2017)
8.3.5 Japan Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.4 Korea Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.4.1 Korea Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.4.2 Korea Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.4.3 Korea Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.4.4 Korea Biologics and Biosimilars Price by Type (2012-2017)
8.4.5 Korea Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.5 India Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.5.1 India Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.5.2 India Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.5.3 India Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.5.4 India Biologics and Biosimilars Price by Type (2012-2017)
8.5.5 India Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.6 Southeast Asia Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.6.1 Southeast Asia Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.6.2 Southeast Asia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.6.3 Southeast Asia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.6.4 Southeast Asia Biologics and Biosimilars Price by Type (2012-2017)
8.6.5 Southeast Asia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
9 MIDDLE EAST AND AFRICA BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
9.1.1 Middle East and Africa Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
9.1.2 Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
9.1.3 Middle East and Africa Biologics and Biosimilars Price by Countries (2012-2017)
9.1.4 Middle East and Africa Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.2 Middle East Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
9.2.1 Middle East Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
9.2.2 Middle East Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
9.2.3 Middle East Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
9.2.4 Middle East Biologics and Biosimilars Price by Type (2012-2017)
9.2.5 Middle East Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
9.3 Africa Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
9.3.1 Africa Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
9.3.2 Africa Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
9.3.3 Africa Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
9.3.4 Africa Biologics and Biosimilars Price by Type (2012-2017)
9.3.5 Africa Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
10 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS
10.1 Biologics and Biosimilars Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Expenses
10.3 Manufacturing Process Analysis of Biologics and Biosimilars
11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
11.1 Biologics and Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
11.4 Downstream Buyers
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2022)
14.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2017-2022)
14.2 Global Biologics and Biosimilars Sales, Consumption Forecast by Countries (2017-2022)
14.3 Global Biologics and Biosimilars Sales Forecast by Type (2017-2022)
14.4 Global Biologics and Biosimilars Sales Forecast by Application (2017-2022)
14.5 Biologics and Biosimilars Price Forecast (2017-2022)
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Analyst Introduction
16.3 Data Source
1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Types
1.2.1 Global Sales Market Share of Biologics and Biosimilars by Types in 2015
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Biologics and Biosimilars Segment by Applications
1.3.1 Biologics and Biosimilars Consumption Market Share by Applications in 2015
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Biologics and Biosimilars Market by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Canada Status and Prospect (2012-2022)
1.4.3 Germany Status and Prospect (2012-2022)
1.4.4 France Status and Prospect (2012-2022)
1.4.5 UK Status and Prospect (2012-2022)
1.4.6 Italy Status and Prospect (2012-2022)
1.4.7 Russia Status and Prospect (2012-2022)
1.4.8 China Status and Prospect (2012-2022)
1.4.9 Japan Status and Prospect (2012-2022)
1.4.10 India Status and Prospect (2012-2022)
1.4.11 Korea Status and Prospect (2012-2022)
1.4.12 Southeast Asia Status and Prospect (2012-2022)
1.4.13 Australia Status and Prospect (2012-2022)
1.4.14 Brazil Status and Prospect (2012-2022)
1.4.15 Mexico Status and Prospect (2012-2022)
1.4.16 Middle East Status and Prospect (2012-2022)
1.4.17 Africa Status and Prospect (2012-2022)
1.5 Global Biologics and Biosimilars Overview and Market Size (Value) (2012-2022)
1.5.1 Global Market Biologics and Biosimilars Overview
1.5.2 Global Market Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
2 GLOBAL BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) AND MARKET SHARE BY MANUFACTURERS
2.1 Global Biologics and Biosimilars Sales and Market Share in 2015 and 2016 by Manufacturers
2.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturers in 2015 and 2016
2.3 Global Biologics and Biosimilars Average Price by Manufacturers in 2015 and 2016
2.4 Global Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
2.5 Biologics and Biosimilars Market Competitive Situation and Trends
2.5.1 Biologics and Biosimilars Market Concentration Rate
2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 GLOBAL BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
3.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
3.1.1 Global Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
3.1.3 Global Biologics and Biosimilars Price by Countries (2012-2017)
3.2 Global Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
3.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
3.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
3.2.3 Global Biologics and Biosimilars Price by Type (2012-2017)
3.3 Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
3.4 Global Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4 GLOBAL BIOLOGICS AND BIOSIMILARS MANUFACTURERS PROFILES/ANALYSIS
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Biologics and Biosimilars Product Types, Application and Specification
4.1.2.1 Type
4.1.2.2 Type
4.1.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.2 Amgen
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Biologics and Biosimilars Product Types, Application and Specification
4.2.2.1 Type
4.2.2.2 Type
4.2.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.3 AbbVie
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Biologics and Biosimilars Product Types, Application and Specification
4.3.2.1 Type
4.3.2.2 Type
4.3.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.4 Sanofi-Aventis
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Biologics and Biosimilars Product Types, Application and Specification
4.4.2.1 Type
4.4.2.2 Type
4.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.5 Johnson & Johnson
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Biologics and Biosimilars Product Types, Application and Specification
4.5.2.1 Type
4.5.2.2 Type
4.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.6 Pfizer
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Biologics and Biosimilars Product Types, Application and Specification
4.6.2.1 Type
4.6.2.2 Type
4.6.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.7 Novo Nordisk
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Biologics and Biosimilars Product Types, Application and Specification
4.7.2.1 Type
4.7.2.2 Type
4.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.8 Eli Lilly
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Biologics and Biosimilars Product Types, Application and Specification
4.8.2.1 Type
4.8.2.2 Type
4.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.9 Novartis
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Biologics and Biosimilars Product Types, Application and Specification
4.9.2.1 Type
4.9.2.2 Type
4.9.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.9.4 Main Business/Business Overview
4.10 Merck
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Biologics and Biosimilars Product Types, Application and Specification
4.10.2.1 Type
4.10.2.2 Type
4.10.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.10.4 Main Business/Business Overview
4.11 3sbio
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Biologics and Biosimilars Product Types, Application and Specification
4.11.2.1 Type
4.11.2.2 Type
4.11.3 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.11.4 Main Business/Business Overview
4.12 Changchun High Tech
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Biologics and Biosimilars Product Types, Application and Specification
4.12.2.1 Type
4.12.2.2 Type
4.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.12.4 Main Business/Business Overview
4.13 CP Guojian
4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.13.2 Biologics and Biosimilars Product Types, Application and Specification
4.13.2.1 Type
4.13.2.2 Type
4.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.13.4 Main Business/Business Overview
4.14 Biotech
4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.14.2 Biologics and Biosimilars Product Types, Application and Specification
4.14.2.1 Type
4.14.2.2 Type
4.14.3 Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.14.4 Main Business/Business Overview
4.15 Gelgen
4.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.15.2 Biologics and Biosimilars Product Types, Application and Specification
4.15.2.1 Type
4.15.2.2 Type
4.15.3 Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.15.4 Main Business/Business Overview
4.16 Innovent
4.16.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.16.2 Biologics and Biosimilars Product Types, Application and Specification
4.16.2.1 Type
4.16.2.2 Type
4.16.3 Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.16.4 Main Business/Business Overview
4.17 Dong Bao
4.17.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.17.2 Biologics and Biosimilars Product Types, Application and Specification
4.17.2.1 Type
4.17.2.2 Type
4.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.17.4 Main Business/Business Overview
4.18 Ganlee
4.18.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.18.2 Biologics and Biosimilars Product Types, Application and Specification
4.18.2.1 Type
4.18.2.2 Type
4.18.3 Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.18.4 Main Business/Business Overview
4.19 United Laboratories
4.19.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.19.2 Biologics and Biosimilars Product Types, Application and Specification
4.19.2.1 Type
4.19.2.2 Type
4.19.3 United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4.19.4 Main Business/Business Overview
5 NORTH AMERICA BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
5.1.1 North America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
5.1.3 North America Biologics and Biosimilars Price by Countries (2012-2017)
5.1.4 North America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
5.1.5 North America Biologics and Biosimilars Import & Export (2012-2017)
5.2 United States Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
5.2.1 United States Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
5.2.2 United States Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
5.2.3 United States Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.2.4 United States Biologics and Biosimilars Price by Type (2012-2017)
5.2.5 United States Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
5.3 Canada Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
5.3.1 Canada Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
5.3.2 Canada Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
5.3.3 Canada Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.3.4 Canada Biologics and Biosimilars Price by Type (2012-2017)
5.3.5 Canada Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
6 LATIN AMERICA BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
6.1 Latin America Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
6.1.1 Latin America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
6.1.2 Latin America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
6.1.3 Latin America Biologics and Biosimilars Price by Countries (2012-2017)
6.1.4 Latin America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.5 Latin America Biologics and Biosimilars Import & Export (2012-2017)
6.2 Mexico Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
6.2.1 Mexico Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
6.2.2 Mexico Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
6.2.3 Mexico Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
6.2.4 Mexico Biologics and Biosimilars Price by Type (2012-2017)
6.2.5 Mexico Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
6.3 Brazil Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
6.3.1 Brazil Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
6.3.2 Brazil Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
6.3.3 Brazil Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
6.3.4 Brazil Biologics and Biosimilars Price by Type (2012-2017)
6.3.5 Brazil Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7 EUROPE BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
7.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
7.1.1 Europe Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
7.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
7.1.3 Europe Biologics and Biosimilars Price by Countries (2012-2017)
7.1.4 Europe Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
7.1.5 Europe Biologics and Biosimilars Import & Export (2012-2017)
7.2 Germany Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.2.1 Germany Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.2.2 Germany Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.2.3 Germany Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.2.4 Germany Biologics and Biosimilars Price by Type (2012-2017)
7.2.5 Germany Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.3 France Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.3.1 France Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.3.2 France Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.3.3 France Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.3.4 France Biologics and Biosimilars Price by Type (2012-2017)
7.3.5 France Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.4 UK Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.4.1 UK Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.4.2 UK Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.4.3 UK Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.4.4 UK Biologics and Biosimilars Price by Type (2012-2017)
7.4.5 UK Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.5 Italy Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.5.1 Italy Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.5.2 Italy Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.5.3 Italy Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.5.4 Italy Biologics and Biosimilars Price by Type (2012-2017)
7.5.5 Italy Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.6 Russia Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
7.6.1 Russia Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
7.6.2 Russia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.6.3 Russia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.6.4 Russia Biologics and Biosimilars Price by Type (2012-2017)
7.6.5 Russia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
8.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
8.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
8.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
8.1.3 Asia-Pacific Biologics and Biosimilars Price by Countries (2012-2017)
8.1.4 Asia-Pacific Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
8.1.5 Asia-Pacific Biologics and Biosimilars Import & Export (2012-2017)
8.2 China Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.2.1 China Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.2.2 China Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.2.3 China Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.2.4 China Biologics and Biosimilars Price by Type (2012-2017)
8.2.5 China Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.3 Japan Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.3.1 Japan Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.3.2 Japan Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.3.3 Japan Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.3.4 Japan Biologics and Biosimilars Price by Type (2012-2017)
8.3.5 Japan Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.4 Korea Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.4.1 Korea Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.4.2 Korea Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.4.3 Korea Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.4.4 Korea Biologics and Biosimilars Price by Type (2012-2017)
8.4.5 Korea Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.5 India Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.5.1 India Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.5.2 India Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.5.3 India Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.5.4 India Biologics and Biosimilars Price by Type (2012-2017)
8.5.5 India Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.6 Southeast Asia Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
8.6.1 Southeast Asia Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
8.6.2 Southeast Asia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.6.3 Southeast Asia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.6.4 Southeast Asia Biologics and Biosimilars Price by Type (2012-2017)
8.6.5 Southeast Asia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
9 MIDDLE EAST AND AFRICA BIOLOGICS AND BIOSIMILARS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)
9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries (2012-2017)
9.1.1 Middle East and Africa Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
9.1.2 Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
9.1.3 Middle East and Africa Biologics and Biosimilars Price by Countries (2012-2017)
9.1.4 Middle East and Africa Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.2 Middle East Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
9.2.1 Middle East Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
9.2.2 Middle East Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
9.2.3 Middle East Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
9.2.4 Middle East Biologics and Biosimilars Price by Type (2012-2017)
9.2.5 Middle East Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
9.3 Africa Biologics and Biosimilars Sales, Revenue and Growth, by Type and Application (2012-2017)
9.3.1 Africa Biologics and Biosimilars Sales, Revenue and Growth Rate (2012-2017)
9.3.2 Africa Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
9.3.3 Africa Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
9.3.4 Africa Biologics and Biosimilars Price by Type (2012-2017)
9.3.5 Africa Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
10 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS
10.1 Biologics and Biosimilars Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Expenses
10.3 Manufacturing Process Analysis of Biologics and Biosimilars
11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
11.1 Biologics and Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
11.4 Downstream Buyers
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2022)
14.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2017-2022)
14.2 Global Biologics and Biosimilars Sales, Consumption Forecast by Countries (2017-2022)
14.3 Global Biologics and Biosimilars Sales Forecast by Type (2017-2022)
14.4 Global Biologics and Biosimilars Sales Forecast by Application (2017-2022)
14.5 Biologics and Biosimilars Price Forecast (2017-2022)
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Analyst Introduction
16.3 Data Source
LIST OF TABLES AND FIGURES
Figure Picture of Biologics and Biosimilars
Table Product Specifications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2015
Table Types of Biologics and Biosimilars
Figure Product Picture of Antibody
Table Major Players of Antibody
Figure Product Picture of Hormone
Table Major Players of Hormone
Figure Product Picture of Growth Factors
Table Major Players of Growth Factors
Figure Product Picture of Other
Table Major Players of Other
Table Biologics and Biosimilars Consumption Market Share by Applications in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Germany Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure France Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure UK Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Italy Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Russia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Korea Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Brazil Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Table Global Biologics and Biosimilars Sales by Manufacturers in 2015 and 2016
Table Global Biologics and Biosimilars Sales Market Share (%) by Manufacturers in 2015 and 2016
Figure Global Biologics and Biosimilars Sales Share by Manufacturers in 2015
Figure Global Biologics and Biosimilars Sales Share by Manufacturers in 2016
Table Global Biologics and Biosimilars Revenue by Manufacturers in 2015 and 2016
Table Global Biologics and Biosimilars Revenue Market Share (%) by Manufacturers in 2015 and 2016
Figure Global Biologics and Biosimilars Revenue Share by Manufacturers in 2015
Figure Global Biologics and Biosimilars Revenue Share by Manufacturers in 2016
Table Global Biologics and Biosimilars Average Price by Manufacturers in 2015 and 2016
Table Global Biologics and Biosimilars Average Price by Manufacturers in 2016
Table Global Biologics and Biosimilars Manufacturing Base Distribution and Sales Area by Manufacturers
Table Manufacturers Biologics and Biosimilars Product Types
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics and Biosimilars Sales by Countries (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Global Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Global Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Global Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Global Biologics and Biosimilars Revenue Market Share by Countries
Table Global Biologics and Biosimilars Price by Countries (2012-2017)
Table Global Biologics and Biosimilars Sales by Type (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Type
Table Global Biologics and Biosimilars Revenue by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Global Biologics and Biosimilars Revenue Market Share by Type
Table Global Biologics and Biosimilars Price by Type (2012-2017)
Table Global Biologics and Biosimilars Sales by Application (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Application
Table Global Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Market Share (2012-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biologics and Biosimilars Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Biologics and Biosimilars Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Biologics and Biosimilars Market Share (2012-2017)
Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure 3sbio Biologics and Biosimilars Market Share (2012-2017)
Table Changchun High Tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changchun High Tech Biologics and Biosimilars Market Share (2012-2017)
Table CP Guojian Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Biologics and Biosimilars Market Share (2012-2017)
Table Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Biologics and Biosimilars Market Share (2012-2017)
Table Gelgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gelgen Biologics and Biosimilars Market Share (2012-2017)
Table Innovent Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Innovent Biologics and Biosimilars Market Share (2012-2017)
Table Dong Bao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dong Bao Biologics and Biosimilars Market Share (2012-2017)
Table Ganlee Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ganlee Biologics and Biosimilars Market Share (2012-2017)
Table United Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure United Laboratories Biologics and Biosimilars Market Share (2012-2017)
Table North America Biologics and Biosimilars Sales by Countries (2012-2017)
Table North America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure North America Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure North America Biologics and Biosimilars Sales Market Share by Countries (2016)
Table North America Biologics and Biosimilars Revenue by Countries (2012-2017)
Table North America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 North America Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 North America Biologics and Biosimilars Revenue Market Share by Countries
Table North America Biologics and Biosimilars Price by Countries (2012-2017)
Table North America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table North America Biologics and Biosimilars Import & Export (2012-2017)
Figure United States Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table United States Biologics and Biosimilars Sales by Type (2012-2017)
Table United States Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure United States Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 United States Biologics and Biosimilars Sales Market Share by Type
Table United States Biologics and Biosimilars Revenue by Type (2012-2017)
Table United States Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure United States Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 United States Biologics and Biosimilars Revenue Market Share by Type
Table United States Biologics and Biosimilars Price by Type (2012-2017)
Table United States Biologics and Biosimilars Sales by Application (2012-2017)
Table United States Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure United States Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 United States Biologics and Biosimilars Sales Market Share by Application
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Canada Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Canada Biologics and Biosimilars Sales by Type (2012-2017)
Table Canada Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Canada Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Canada Biologics and Biosimilars Sales Market Share by Type
Table Canada Biologics and Biosimilars Revenue by Type (2012-2017)
Table Canada Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Canada Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Canada Biologics and Biosimilars Revenue Market Share by Type
Table Canada Biologics and Biosimilars Price by Type (2012-2017)
Table Canada Biologics and Biosimilars Sales by Application (2012-2017)
Table Canada Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Canada Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Canada Biologics and Biosimilars Sales Market Share by Application
Table Latin America Biologics and Biosimilars Sales by Countries (2012-2017)
Table Latin America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Latin America Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Latin America Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Latin America Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Latin America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Latin America Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Latin America Biologics and Biosimilars Revenue Market Share by Countries
Table Latin America Biologics and Biosimilars Price by Countries (2012-2017)
Table Latin America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Latin America Biologics and Biosimilars Import & Export (2012-2017)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Mexico Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Mexico Biologics and Biosimilars Sales by Type (2012-2017)
Table Mexico Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Mexico Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Mexico Biologics and Biosimilars Sales Market Share by Type
Table Mexico Biologics and Biosimilars Revenue by Type (2012-2017)
Table Mexico Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Mexico Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Mexico Biologics and Biosimilars Revenue Market Share by Type
Table Mexico Biologics and Biosimilars Price by Type (2012-2017)
Table Mexico Biologics and Biosimilars Sales by Application (2012-2017)
Table Mexico Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Mexico Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Mexico Biologics and Biosimilars Sales Market Share by Application
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Brazil Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Brazil Biologics and Biosimilars Sales by Type (2012-2017)
Table Brazil Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Brazil Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Brazil Biologics and Biosimilars Sales Market Share by Type
Table Brazil Biologics and Biosimilars Revenue by Type (2012-2017)
Table Brazil Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Brazil Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Brazil Biologics and Biosimilars Revenue Market Share by Type
Table Brazil Biologics and Biosimilars Price by Type (2012-2017)
Table Brazil Biologics and Biosimilars Sales by Application (2012-2017)
Table Brazil Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Brazil Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Brazil Biologics and Biosimilars Sales Market Share by Application
Table Europe Biologics and Biosimilars Sales by Countries (2012-2017)
Table Europe Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Europe Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Europe Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Europe Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Europe Biologics and Biosimilars Revenue Market Share by Countries
Table Europe Biologics and Biosimilars Price by Countries (2012-2017)
Table Europe Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Europe Biologics and Biosimilars Import & Export (2012-2017)
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Germany Biologics and Biosimilars Sales by Type (2012-2017)
Table Germany Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Germany Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Germany Biologics and Biosimilars Sales Market Share by Type
Table Germany Biologics and Biosimilars Revenue by Type (2012-2017)
Table Germany Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Germany Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Germany Biologics and Biosimilars Revenue Market Share by Type
Table Germany Biologics and Biosimilars Price by Type (2012-2017)
Table Germany Biologics and Biosimilars Sales by Application (2012-2017)
Table Germany Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Germany Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Germany Biologics and Biosimilars Sales Market Share by Application
Figure France Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table France Biologics and Biosimilars Sales by Type (2012-2017)
Table France Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure France Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 France Biologics and Biosimilars Sales Market Share by Type
Table France Biologics and Biosimilars Revenue by Type (2012-2017)
Table France Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure France Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 France Biologics and Biosimilars Revenue Market Share by Type
Table France Biologics and Biosimilars Price by Type (2012-2017)
Table France Biologics and Biosimilars Sales by Application (2012-2017)
Table France Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure France Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 France Biologics and Biosimilars Sales Market Share by Application
Figure UK Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table UK Biologics and Biosimilars Sales by Type (2012-2017)
Table UK Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure UK Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 UK Biologics and Biosimilars Sales Market Share by Type
Table UK Biologics and Biosimilars Revenue by Type (2012-2017)
Table UK Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure UK Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 UK Biologics and Biosimilars Revenue Market Share by Type
Table UK Biologics and Biosimilars Price by Type (2012-2017)
Table UK Biologics and Biosimilars Sales by Application (2012-2017)
Table UK Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure UK Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 UK Biologics and Biosimilars Sales Market Share by Application
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Italy Biologics and Biosimilars Sales by Type (2012-2017)
Table Italy Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Italy Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Italy Biologics and Biosimilars Sales Market Share by Type
Table Italy Biologics and Biosimilars Revenue by Type (2012-2017)
Table Italy Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Italy Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Italy Biologics and Biosimilars Revenue Market Share by Type
Table Italy Biologics and Biosimilars Price by Type (2012-2017)
Table Italy Biologics and Biosimilars Sales by Application (2012-2017)
Table Italy Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Italy Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Italy Biologics and Biosimilars Sales Market Share by Application
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Russia Biologics and Biosimilars Sales by Type (2012-2017)
Table Russia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Russia Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Russia Biologics and Biosimilars Sales Market Share by Type
Table Russia Biologics and Biosimilars Revenue by Type (2012-2017)
Table Russia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Russia Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Russia Biologics and Biosimilars Revenue Market Share by Type
Table Russia Biologics and Biosimilars Price by Type (2012-2017)
Table Russia Biologics and Biosimilars Sales by Application (2012-2017)
Table Russia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Russia Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Russia Biologics and Biosimilars Sales Market Share by Application
Table Asia-Pacific Biologics and Biosimilars Sales by Countries (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Asia-Pacific Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries
Table Asia-Pacific Biologics and Biosimilars Price by Countries (2012-2017)
Table Asia-Pacific Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Import & Export (2012-2017)
Figure China Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table China Biologics and Biosimilars Sales by Type (2012-2017)
Table China Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure China Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 China Biologics and Biosimilars Sales Market Share by Type
Table China Biologics and Biosimilars Revenue by Type (2012-2017)
Table China Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure China Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 China Biologics and Biosimilars Revenue Market Share by Type
Table China Biologics and Biosimilars Price by Type (2012-2017)
Table China Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure China Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 China Biologics and Biosimilars Sales Market Share by Application
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Japan Biologics and Biosimilars Sales by Type (2012-2017)
Table Japan Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Japan Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Japan Biologics and Biosimilars Sales Market Share by Type
Table Japan Biologics and Biosimilars Revenue by Type (2012-2017)
Table Japan Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Japan Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Japan Biologics and Biosimilars Revenue Market Share by Type
Table Japan Biologics and Biosimilars Price by Type (2012-2017)
Table Japan Biologics and Biosimilars Sales by Application (2012-2017)
Table Japan Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Japan Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Japan Biologics and Biosimilars Sales Market Share by Application
Figure Korea Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Korea Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Korea Biologics and Biosimilars Sales by Type (2012-2017)
Table Korea Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Korea Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Korea Biologics and Biosimilars Sales Market Share by Type
Table Korea Biologics and Biosimilars Revenue by Type (2012-2017)
Table Korea Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Korea Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Korea Biologics and Biosimilars Revenue Market Share by Type
Table Korea Biologics and Biosimilars Price by Type (2012-2017)
Table Korea Biologics and Biosimilars Sales by Application (2012-2017)
Table Korea Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Korea Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Korea Biologics and Biosimilars Sales Market Share by Application
Figure India Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure India Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table India Biologics and Biosimilars Sales by Type (2012-2017)
Table India Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure India Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 India Biologics and Biosimilars Sales Market Share by Type
Table India Biologics and Biosimilars Revenue by Type (2012-2017)
Table India Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure India Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 India Biologics and Biosimilars Revenue Market Share by Type
Table India Biologics and Biosimilars Price by Type (2012-2017)
Table India Biologics and Biosimilars Sales by Application (2012-2017)
Table India Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure India Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 India Biologics and Biosimilars Sales Market Share by Application
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Southeast Asia Biologics and Biosimilars Sales Market Share by Type
Table Southeast Asia Biologics and Biosimilars Revenue by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Southeast Asia Biologics and Biosimilars Revenue Market Share by Type
Table Southeast Asia Biologics and Biosimilars Price by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales by Application (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Southeast Asia Biologics and Biosimilars Sales Market Share by Application
Table Middle East and Africa Biologics and Biosimilars Sales by Countries (2012-2017)
Table Middle East and Africa Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Middle East and Africa Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries
Table Middle East and Africa Biologics and Biosimilars Price by Countries (2012-2017)
Table Middle East and Africa Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Middle East Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Middle East Biologics and Biosimilars Sales by Type (2012-2017)
Table Middle East Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Middle East Biologics and Biosimilars Sales Market Share by Type
Table Middle East Biologics and Biosimilars Revenue by Type (2012-2017)
Table Middle East Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Middle East Biologics and Biosimilars Revenue Market Share by Type
Table Middle East Biologics and Biosimilars Price by Type (2012-2017)
Table Middle East Biologics and Biosimilars Sales by Application (2012-2017)
Table Middle East Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Middle East Biologics and Biosimilars Sales Market Share by Application
Figure Africa Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Africa Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Africa Biologics and Biosimilars Sales by Type (2012-2017)
Table Africa Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Africa
Figure Picture of Biologics and Biosimilars
Table Product Specifications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2015
Table Types of Biologics and Biosimilars
Figure Product Picture of Antibody
Table Major Players of Antibody
Figure Product Picture of Hormone
Table Major Players of Hormone
Figure Product Picture of Growth Factors
Table Major Players of Growth Factors
Figure Product Picture of Other
Table Major Players of Other
Table Biologics and Biosimilars Consumption Market Share by Applications in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Germany Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure France Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure UK Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Italy Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Russia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Korea Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Brazil Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Table Global Biologics and Biosimilars Sales by Manufacturers in 2015 and 2016
Table Global Biologics and Biosimilars Sales Market Share (%) by Manufacturers in 2015 and 2016
Figure Global Biologics and Biosimilars Sales Share by Manufacturers in 2015
Figure Global Biologics and Biosimilars Sales Share by Manufacturers in 2016
Table Global Biologics and Biosimilars Revenue by Manufacturers in 2015 and 2016
Table Global Biologics and Biosimilars Revenue Market Share (%) by Manufacturers in 2015 and 2016
Figure Global Biologics and Biosimilars Revenue Share by Manufacturers in 2015
Figure Global Biologics and Biosimilars Revenue Share by Manufacturers in 2016
Table Global Biologics and Biosimilars Average Price by Manufacturers in 2015 and 2016
Table Global Biologics and Biosimilars Average Price by Manufacturers in 2016
Table Global Biologics and Biosimilars Manufacturing Base Distribution and Sales Area by Manufacturers
Table Manufacturers Biologics and Biosimilars Product Types
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics and Biosimilars Sales by Countries (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Global Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Global Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Global Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Global Biologics and Biosimilars Revenue Market Share by Countries
Table Global Biologics and Biosimilars Price by Countries (2012-2017)
Table Global Biologics and Biosimilars Sales by Type (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Type
Table Global Biologics and Biosimilars Revenue by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Global Biologics and Biosimilars Revenue Market Share by Type
Table Global Biologics and Biosimilars Price by Type (2012-2017)
Table Global Biologics and Biosimilars Sales by Application (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Application
Table Global Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Market Share (2012-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biologics and Biosimilars Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Biologics and Biosimilars Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Biologics and Biosimilars Market Share (2012-2017)
Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure 3sbio Biologics and Biosimilars Market Share (2012-2017)
Table Changchun High Tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changchun High Tech Biologics and Biosimilars Market Share (2012-2017)
Table CP Guojian Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Biologics and Biosimilars Market Share (2012-2017)
Table Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Biologics and Biosimilars Market Share (2012-2017)
Table Gelgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gelgen Biologics and Biosimilars Market Share (2012-2017)
Table Innovent Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Innovent Biologics and Biosimilars Market Share (2012-2017)
Table Dong Bao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dong Bao Biologics and Biosimilars Market Share (2012-2017)
Table Ganlee Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ganlee Biologics and Biosimilars Market Share (2012-2017)
Table United Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure United Laboratories Biologics and Biosimilars Market Share (2012-2017)
Table North America Biologics and Biosimilars Sales by Countries (2012-2017)
Table North America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure North America Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure North America Biologics and Biosimilars Sales Market Share by Countries (2016)
Table North America Biologics and Biosimilars Revenue by Countries (2012-2017)
Table North America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 North America Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 North America Biologics and Biosimilars Revenue Market Share by Countries
Table North America Biologics and Biosimilars Price by Countries (2012-2017)
Table North America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table North America Biologics and Biosimilars Import & Export (2012-2017)
Figure United States Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table United States Biologics and Biosimilars Sales by Type (2012-2017)
Table United States Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure United States Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 United States Biologics and Biosimilars Sales Market Share by Type
Table United States Biologics and Biosimilars Revenue by Type (2012-2017)
Table United States Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure United States Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 United States Biologics and Biosimilars Revenue Market Share by Type
Table United States Biologics and Biosimilars Price by Type (2012-2017)
Table United States Biologics and Biosimilars Sales by Application (2012-2017)
Table United States Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure United States Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 United States Biologics and Biosimilars Sales Market Share by Application
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Canada Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Canada Biologics and Biosimilars Sales by Type (2012-2017)
Table Canada Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Canada Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Canada Biologics and Biosimilars Sales Market Share by Type
Table Canada Biologics and Biosimilars Revenue by Type (2012-2017)
Table Canada Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Canada Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Canada Biologics and Biosimilars Revenue Market Share by Type
Table Canada Biologics and Biosimilars Price by Type (2012-2017)
Table Canada Biologics and Biosimilars Sales by Application (2012-2017)
Table Canada Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Canada Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Canada Biologics and Biosimilars Sales Market Share by Application
Table Latin America Biologics and Biosimilars Sales by Countries (2012-2017)
Table Latin America Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Latin America Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Latin America Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Latin America Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Latin America Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Latin America Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Latin America Biologics and Biosimilars Revenue Market Share by Countries
Table Latin America Biologics and Biosimilars Price by Countries (2012-2017)
Table Latin America Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Latin America Biologics and Biosimilars Import & Export (2012-2017)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Mexico Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Mexico Biologics and Biosimilars Sales by Type (2012-2017)
Table Mexico Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Mexico Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Mexico Biologics and Biosimilars Sales Market Share by Type
Table Mexico Biologics and Biosimilars Revenue by Type (2012-2017)
Table Mexico Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Mexico Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Mexico Biologics and Biosimilars Revenue Market Share by Type
Table Mexico Biologics and Biosimilars Price by Type (2012-2017)
Table Mexico Biologics and Biosimilars Sales by Application (2012-2017)
Table Mexico Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Mexico Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Mexico Biologics and Biosimilars Sales Market Share by Application
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Brazil Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Brazil Biologics and Biosimilars Sales by Type (2012-2017)
Table Brazil Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Brazil Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Brazil Biologics and Biosimilars Sales Market Share by Type
Table Brazil Biologics and Biosimilars Revenue by Type (2012-2017)
Table Brazil Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Brazil Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Brazil Biologics and Biosimilars Revenue Market Share by Type
Table Brazil Biologics and Biosimilars Price by Type (2012-2017)
Table Brazil Biologics and Biosimilars Sales by Application (2012-2017)
Table Brazil Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Brazil Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Brazil Biologics and Biosimilars Sales Market Share by Application
Table Europe Biologics and Biosimilars Sales by Countries (2012-2017)
Table Europe Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Europe Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Europe Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Europe Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Europe Biologics and Biosimilars Revenue Market Share by Countries
Table Europe Biologics and Biosimilars Price by Countries (2012-2017)
Table Europe Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Europe Biologics and Biosimilars Import & Export (2012-2017)
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Germany Biologics and Biosimilars Sales by Type (2012-2017)
Table Germany Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Germany Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Germany Biologics and Biosimilars Sales Market Share by Type
Table Germany Biologics and Biosimilars Revenue by Type (2012-2017)
Table Germany Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Germany Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Germany Biologics and Biosimilars Revenue Market Share by Type
Table Germany Biologics and Biosimilars Price by Type (2012-2017)
Table Germany Biologics and Biosimilars Sales by Application (2012-2017)
Table Germany Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Germany Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Germany Biologics and Biosimilars Sales Market Share by Application
Figure France Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table France Biologics and Biosimilars Sales by Type (2012-2017)
Table France Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure France Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 France Biologics and Biosimilars Sales Market Share by Type
Table France Biologics and Biosimilars Revenue by Type (2012-2017)
Table France Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure France Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 France Biologics and Biosimilars Revenue Market Share by Type
Table France Biologics and Biosimilars Price by Type (2012-2017)
Table France Biologics and Biosimilars Sales by Application (2012-2017)
Table France Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure France Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 France Biologics and Biosimilars Sales Market Share by Application
Figure UK Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table UK Biologics and Biosimilars Sales by Type (2012-2017)
Table UK Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure UK Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 UK Biologics and Biosimilars Sales Market Share by Type
Table UK Biologics and Biosimilars Revenue by Type (2012-2017)
Table UK Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure UK Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 UK Biologics and Biosimilars Revenue Market Share by Type
Table UK Biologics and Biosimilars Price by Type (2012-2017)
Table UK Biologics and Biosimilars Sales by Application (2012-2017)
Table UK Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure UK Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 UK Biologics and Biosimilars Sales Market Share by Application
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Italy Biologics and Biosimilars Sales by Type (2012-2017)
Table Italy Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Italy Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Italy Biologics and Biosimilars Sales Market Share by Type
Table Italy Biologics and Biosimilars Revenue by Type (2012-2017)
Table Italy Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Italy Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Italy Biologics and Biosimilars Revenue Market Share by Type
Table Italy Biologics and Biosimilars Price by Type (2012-2017)
Table Italy Biologics and Biosimilars Sales by Application (2012-2017)
Table Italy Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Italy Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Italy Biologics and Biosimilars Sales Market Share by Application
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Russia Biologics and Biosimilars Sales by Type (2012-2017)
Table Russia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Russia Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Russia Biologics and Biosimilars Sales Market Share by Type
Table Russia Biologics and Biosimilars Revenue by Type (2012-2017)
Table Russia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Russia Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Russia Biologics and Biosimilars Revenue Market Share by Type
Table Russia Biologics and Biosimilars Price by Type (2012-2017)
Table Russia Biologics and Biosimilars Sales by Application (2012-2017)
Table Russia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Russia Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Russia Biologics and Biosimilars Sales Market Share by Application
Table Asia-Pacific Biologics and Biosimilars Sales by Countries (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Asia-Pacific Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries
Table Asia-Pacific Biologics and Biosimilars Price by Countries (2012-2017)
Table Asia-Pacific Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Import & Export (2012-2017)
Figure China Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table China Biologics and Biosimilars Sales by Type (2012-2017)
Table China Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure China Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 China Biologics and Biosimilars Sales Market Share by Type
Table China Biologics and Biosimilars Revenue by Type (2012-2017)
Table China Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure China Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 China Biologics and Biosimilars Revenue Market Share by Type
Table China Biologics and Biosimilars Price by Type (2012-2017)
Table China Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure China Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 China Biologics and Biosimilars Sales Market Share by Application
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Japan Biologics and Biosimilars Sales by Type (2012-2017)
Table Japan Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Japan Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Japan Biologics and Biosimilars Sales Market Share by Type
Table Japan Biologics and Biosimilars Revenue by Type (2012-2017)
Table Japan Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Japan Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Japan Biologics and Biosimilars Revenue Market Share by Type
Table Japan Biologics and Biosimilars Price by Type (2012-2017)
Table Japan Biologics and Biosimilars Sales by Application (2012-2017)
Table Japan Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Japan Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Japan Biologics and Biosimilars Sales Market Share by Application
Figure Korea Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Korea Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Korea Biologics and Biosimilars Sales by Type (2012-2017)
Table Korea Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Korea Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Korea Biologics and Biosimilars Sales Market Share by Type
Table Korea Biologics and Biosimilars Revenue by Type (2012-2017)
Table Korea Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Korea Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Korea Biologics and Biosimilars Revenue Market Share by Type
Table Korea Biologics and Biosimilars Price by Type (2012-2017)
Table Korea Biologics and Biosimilars Sales by Application (2012-2017)
Table Korea Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Korea Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Korea Biologics and Biosimilars Sales Market Share by Application
Figure India Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure India Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table India Biologics and Biosimilars Sales by Type (2012-2017)
Table India Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure India Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 India Biologics and Biosimilars Sales Market Share by Type
Table India Biologics and Biosimilars Revenue by Type (2012-2017)
Table India Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure India Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 India Biologics and Biosimilars Revenue Market Share by Type
Table India Biologics and Biosimilars Price by Type (2012-2017)
Table India Biologics and Biosimilars Sales by Application (2012-2017)
Table India Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure India Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 India Biologics and Biosimilars Sales Market Share by Application
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Southeast Asia Biologics and Biosimilars Sales Market Share by Type
Table Southeast Asia Biologics and Biosimilars Revenue by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Southeast Asia Biologics and Biosimilars Revenue Market Share by Type
Table Southeast Asia Biologics and Biosimilars Price by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales by Application (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Southeast Asia Biologics and Biosimilars Sales Market Share by Application
Table Middle East and Africa Biologics and Biosimilars Sales by Countries (2012-2017)
Table Middle East and Africa Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2012)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2016)
Table Middle East and Africa Biologics and Biosimilars Revenue by Countries (2012-2017)
Table Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Figure 2012 Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries
Figure 2016 Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries
Table Middle East and Africa Biologics and Biosimilars Price by Countries (2012-2017)
Table Middle East and Africa Market Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Middle East Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Middle East Biologics and Biosimilars Sales by Type (2012-2017)
Table Middle East Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Middle East Biologics and Biosimilars Sales Market Share by Type
Table Middle East Biologics and Biosimilars Revenue by Type (2012-2017)
Table Middle East Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Middle East Biologics and Biosimilars Revenue Market Share by Type
Table Middle East Biologics and Biosimilars Price by Type (2012-2017)
Table Middle East Biologics and Biosimilars Sales by Application (2012-2017)
Table Middle East Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Middle East Biologics and Biosimilars Sales Market Share by Application
Figure Africa Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Africa Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Africa Biologics and Biosimilars Sales by Type (2012-2017)
Table Africa Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Africa
